The art of measuring gastrin in plasma: a dwindling diagnostic discipline?
The gastrointestinal hormone gastrin is measured in plasma in physiological, pathophysiological and diagnostic investigations. In the diagnosis of hypergastrinaemic diseases such as gastrinomas and gastric achlorhydria, measurement of gastrin concentrations in circulation is crucial. Gastrin circulates, however, not as a single peptide but as a mixture of peptides of different lengths and amino acid derivatizations. Moreover, in hypergastrinaemia the peptide pattern changes. Consequently, diagnostic gastrin measurements require immunoassays that recognize the pathological plasma patterns, which are characterized by a predominance of the large peptides (gastrin-34 and gastrin-71) and less, if any, of the shorter main form of gastrin in normal tissue, gastrin-17. Alternatively, and in specific cases, "processing-independent assays" (PIA) for progastrin may be considered, since hypersecreting gastrin cells also release substantial amounts of biosynthetic precursors and processing intermediates. Recently, gastrin kits that do not take the pathological plasma patterns into account have been marketed and may miss the diagnosis. Therefore, proper diagnosis of gastrinomas and other hypergastrinaemic diseases requires insight into cellular gastrin synthesis and peripheral metabolism, and also into the design of useful immunoassays. This review discusses the art of measuring gastrin in plasma with adequate diagnostic specificity.
Rehfeld
Jens F
JF
Department of Clinical Biochemistry, Rigshospitalet, University Hospital of Copenhagen, Denmark. jens.f.rehfeld@rh.regionh.dk
D000818:Animals; D004194:Disease; D005755:Gastrins / Q000096:biosynthesis / Q000097:blood* / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D014176:Protein Biosynthesis / Q000235:genetics; D013272:Stomach Diseases / Q000097:blood / Q000175:diagnosis; D014158:Transcription, Genetic / Q000235:genetics
D005755:Gastrins